CD8 + T cells responding to influenza infection reach and persist at higher numbers than CD4 + T cells independently of precursor frequency

Clinical Immunology

Volumn 113, Issue 1, 2004, Pages 89-100

  Powell, Timothy J ^a   Brown, Deborah M ^a   Hollenbaugh, Joseph A ^a   Charbonneau, Tina ^a   Kemp, Roslyn A ^a   Swain, Susan L ^a   Dutton, Richard W ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

BAL; bronchoalveolar lavage; Cell surface molecules; Cellular activation; Cellular proliferation; DLN; draining lymph nodes; HA; hemagglutinin; NDLN; nondraining lymph nodes; T lymphocytes; Virus infection

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIVISION; CELL KINETICS; CELL TRANSFER; CELL TYPE; CONTROLLED STUDY; CYTOLYSIS; INFLUENZA; LUNG; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; GENETICS; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; INTERFERON TYPE II; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, ANTIGEN, T-CELL;

EID: 6044253358     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.05.006     Document Type: Article

References (51)

1. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:1994;287-299
2. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:2002;251-262
3. Dutton R.W., Bradley L.M., Swain S.L. T cell memory. Annu. Rev. Immunol. 16:1998;201-223
4. Jenkins M.K., Khoruts A., Ingulli E., Mueller D.L., McSorley S.J., Reinhardt R.L., Itano A., Pape K.A. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:2001;23-45
5. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18:2000;275-308
6. Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161:1998;5338-5346
7. + T cell responses. J. Immunol. 166:2001;4627-4633
8. Wong P., Pamer E.G. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21:2003;29-70
9. Harty J.T., Badovinac V.P. Influence of effector molecules on the CD8(+) T cell response to infection. Curr. Opin. Immunol. 14:2002;360-365
10. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159:1997;105-117
11. + T cells in primary and secondary influenza pneumonia. Immunity. 8:1998;683-691
12. Flynn K.J., Riberdy J.M., Christensen J.P., Altman J.D., Doherty P.C. In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8597-8602
13. Haanen J.B., Toebes M., Cordaro T.A., Wolkers M.C., Kruisbeek A.M., Schumacher T.N. Systemic T cell expansion during localized viral infection. Eur. J. Immunol. 29:1999;1168-1174
14. + T cells during an acute virus infection. Immunity. 8:1998;167-175
15. Kim S.K., Schluns K.S., Lefrancois L. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J. Immunol. 163:1999;4125-4132
16. Cerwenka A., Morgan T.M., Harmsen A.G., Dutton R.W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:1999;423-434
17. Cerwenka A., Morgan T.M., Dutton R.W. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163:1999;5535-5543
18. Roman E., Miller E., Harmsen A., Wiley J., Von Andrian U.H., Huston G., Swain S.L. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196:2002;957-968
19. Kim S.K., Reed D.S., Heath W.R., Carbone F., Lefrancois L. Activation and migration of CD8 T cells in the intestinal mucosa. J. Immunol. 159:1997;4295-4306
20. Reinhardt R.L., Bullard D.C., Weaver C.T., Jenkins M.K. Preferential accumulation of antigen-specific effector CD4 T cells at an antigen injection site involves CD62E-dependent migration but not local proliferation. J. Exp. Med. 197:2003;751-762
21. + T cells. J. Immunol. 144:1990;3980-3986
22. + T cells. J. Exp. Med. 174:1991;875-880
23. Bender B.S., Croghan T., Zhang L., Small P.A. Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1992;1143-1145
24. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells. Virology. 239:1997;217-225
25. + T cells is inefficient in the absence of B cells. J. Virol. 72:1998;882-885
26. Epstein S.L., Lo C.Y., Misplon J.A., Bennink J.R. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160:1998;322-327
27. + T-cell memory. Nat. Med. 7:2001;913-919
28. Foulds K.E., Zenewicz L.A., Shedlock D.J., Jiang J., Troy A.E., Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:2002;1528-1532
29. Morgan D.J., Liblau R., Scott B., Fleck S., McDevitt H.O., Sarvetnick N., Lo D., Sherman L.A. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:1996;978-983
30. Scott B., Liblau R., Degermann S., Marconi L.A., Ogata L., Caton A.J., McDevitt H.O., Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity. 1:1994;73-83
31. Jelley-Gibbs D.M., Lepak N.M., Yen M., Swain S.L. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J. Immunol. 165:2000;5017-5026
32. Kemp R.A., Ronchese F. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. J. Immunol. 167:2001;6497-6502
33. Lund F.E., Partida-Sanchez S., Lee B.O., Kusser K.L., Hartson L., Hogan R.J., Woodland D.L., Randall T.D. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J. Immunol. 169:2002;5236-5243
34. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1995;1357-1367
35. Morris A.G., Lin Y.L., Askonas B.A. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature. 295:1982;150-152
36. Klein J.R., Raulet D.H., Pasternack M.S., Bevan M.J. Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J. Exp. Med. 155:1982;1198-1203
37. Gudmundsdottir H., Wells A.D., Turka L.A. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162:1999;5212-5223
38. Auphan-Anezin N., Verdeil G., Schmitt-Verhulst A.-M. Distinct thresholds for CD8 T cell activation lead to functional heterogeneity: CD8 T cell priming can occur independently of cell division. J. Immunol. 170:2003;2442-2448
39. Hernandez J., Aung S., Marquardt K., Sherman L.A. Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J. Exp. Med. 196:2002;323-333
40. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166:2001;1813-1822
41. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712
42. Harrington L.E., Galvan M., Baum L.G., Altman J.D., Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:2000;1241-1246
43. + T cells. J. Immunol. 155:1995;1873-1883
44. Hanninen A., Jaakkola I., Salmi M., Simell O., Jalkanen S. Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6898-6903
45. + T cells in influenza virus-infected mice. Proc. Natl. Acad. Sci. U. S. A. 100:2003;2657-2662
46. Cauley L.S., Cookenham T., Miller T.B., Adams P.S., Vignali K.M., Vignali D.A., Woodland D.L. Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J. Immunol. 169:2002;6655-6658
47. Humphreys I.R., Walzl G., Edwards L., Rae A., Hill S., Hussell T. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 198:2003;1237-1242
48. Hendriks J., Gravestein L.A., Tesselaar K., van Lier R.A., Schumacher T.N., Borst J. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:2000;433-440
49. Kuijpers K.C., van Kemenade F.J., Hooibrink B., Neefjes J.J., Lucas C.J., van Lier R.A., Miedema F. HLA class I and II molecules present influenza virus antigens with different kinetics. Eur. J. Immunol. 22:1992;2339-2345
50. Deng Y., Yewdell J.W., Eisenlohr L.C., Bennink J.R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1997;1507-1515
51. Seder R.A., Ahmed R. Similarities and differences in CD4(+) and CD8(+) effector and memory T cell generation. Nat. Immunol. 4:2003;835-842